Clinical Research Directory
Browse clinical research sites, groups, and studies.
GyroGlove Use in Essential Tremor Patients
Sponsor: GyroGear Ltd
Summary
This is a multi-centre, single-blind, placebo-controlled trial with an open label follow up. After the baseline assessment, all participants will receive the GyroGlove for two weeks during the open label follow up part of the trial. All gloves will be retrieved and returned to GyroGear after closure of the study.
Official title: Effectiveness and Safety of GyroGlove in Stabilising Hand Tremors in Essential Tremor
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-07
Completion Date
2025-12
Last Updated
2025-03-14
Healthy Volunteers
No
Conditions
Interventions
Placebo
The placebo device consists of the same hardware as GyroGlove: aesthetically it looks the same, weight same and produces the same noise as GyroGlove. Participants will interact with Placebo on the day of baseline visit (i.e. Day 0).
GyroGlove
GyroGlove is a patented wearable device containing high-performance, miniaturised, gyroscopes designed for individuals diagnosed with essential tremor. Participants will interact with GyroGlove on the day of baseline visit (i.e. Day 0), 2-week Home use and on the day of follow-up visit (i.e Day 14).
Locations (7)
Quest Research Institute
Farmington Hills, Michigan, United States
Houston Methodist Stanley H. Appel Department of Neurology
Houston, Texas, United States
University of Vermont Medical Centre
Burlington, Vermont, United States
Addenbrooke Hospital, Cambridge University Hospital NHS Trust
Cambridge, England, United Kingdom
Clinical Ageing Research Unit, Newcastle University
Newcastle, England, United Kingdom
Oxford University Hospitals NHS Foundation Trust, UK
Oxford, England, United Kingdom
North Tyneside General Hospital
Newcastle, United Kingdom